相关实验视频
Updated: Jul 13, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.1K
扩散型大B细胞淋巴瘤的预后指数:基于多种模型的基于人口的比较和验证研究
Jelena Jelicic1,2, Karen Juul-Jensen2, Zoran Bukumiric3
1Department of Hematology, Vejle Hospital, Sygehus Lillebaelt, Vejle, Denmark.
Blood cancer journal
|October 13, 2023
概括
国家综合癌症网络IPI (NCCN-IPI) 显示,在扩散性大B细胞淋巴瘤 (DLBCL) 患者的生存预测中,其准确度很高. 这项研究表明,NCCN-IPI应该成为DLBCL预后的参考模型.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床流行病学临床流行病学
背景情况:
- 国际预后指数 (IPI) 被广泛用于扩散大B细胞淋巴瘤 (DLBCL) 的预后.
- 已经提出了几种IPI变体,包括修订的IPI (R-IPI) 和国家综合癌症网络IPI (NCCN-IPI),但需要验证.
研究的目的:
- 验证和比较各种IPI类模型对新诊断的DLBCL患者的生存的预测准确度.
- 确定DLBCL最准确的预后模型.
主要方法:
- 对5126名DLBCL患者的回顾性分析,这些患者接受了免疫化学疗法.
- 对13种不同的预后模型进行比较,包括IPI及其变异.
- 基于预测准确性,区分和校准的模型性能评估.
主要成果:
- 所有评估的模型都表现出预测生存率的能力.
- 该NCCN-IPI始终表现出高的预测准确度.
- 在NCCN-IPI高风险组的五年整体存活率为33.4%,与先前的验证一致.
- 具有较少风险组或缺乏年龄作为因素的模型表现较差.
结论:
- NCCN-IPI是新诊断的DLBCL患者的高度准确的预后模型.
- 应该将NCCN-IPI作为参考模型与DLBCL的传统IPI一起报告.
- 进一步验证DLBCL的新预后模型是有必要的.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
202
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
202
Cancer Survival Analysis
359
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
359

